These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23303817)

  • 1. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network.
    Stalker TJ; Traxler EA; Wu J; Wannemacher KM; Cermignano SL; Voronov R; Diamond SL; Brass LF
    Blood; 2013 Mar; 121(10):1875-85. PubMed ID: 23303817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature.
    Welsh JD; Poventud-Fuentes I; Sampietro S; Diamond SL; Stalker TJ; Brass LF
    J Thromb Haemost; 2017 Mar; 15(3):526-537. PubMed ID: 27992950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
    Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
    Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.
    Xiang B; Zhang G; Ren H; Sunkara M; Morris AJ; Gartner TK; Smyth SS; Li Z
    PLoS One; 2012; 7(12):e51037. PubMed ID: 23236426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature.
    Welsh JD; Muthard RW; Stalker TJ; Taliaferro JP; Diamond SL; Brass LF
    Blood; 2016 Mar; 127(12):1598-605. PubMed ID: 26738537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets.
    Larson MK; Chen H; Kahn ML; Taylor AM; Fabre JE; Mortensen RM; Conley PB; Parise LV
    Blood; 2003 Feb; 101(4):1409-15. PubMed ID: 12393417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts.
    Yang XM; Liu Y; Cui L; Yang X; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):251-62. PubMed ID: 23233653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin by activation of adenosine A
    Rukoyatkina N; Shpakova V; Bogoutdinova A; Kharazova A; Mindukshev I; Gambaryan S
    Biochem Biophys Res Commun; 2022 Jan; 586():20-26. PubMed ID: 34823218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet activation and thrombosis in transgenic mice expressing constitutively active P2Y12.
    Zhang Y; Ye J; Hu L; Zhang S; Zhang SH; Li Y; Kunapuli SP; Ding Z
    J Thromb Haemost; 2012 Oct; 10(10):2149-57. PubMed ID: 22906019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
    Schweigel H; Geiger J; Beck F; Buhs S; Gerull H; Walter U; Sickmann A; Nollau P
    Proteomics; 2013 Mar; 13(6):1016-27. PubMed ID: 23322602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y
    Hensch NR; Karim ZA; Pineda J; Mercado N; Alshbool FZ; Khasawneh FT
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1069-1074. PubMed ID: 28928091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
    Iyú D; Glenn JR; White AE; Fox SC; Dovlatova N; Heptinstall S
    Platelets; 2011; 22(7):504-15. PubMed ID: 21591981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the antiplatelet effects of cangrelor be reliably studied in mice under in vivo and in vitro conditions using flow cytometry?
    Kassassir H; Siewiera K; Sychowski R; Watała C
    Pharmacol Rep; 2013; 65(4):870-83. PubMed ID: 24145081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships between structure and function during the hemostatic response to injury.
    Tomaiuolo M; Matzko CN; Poventud-Fuentes I; Weisel JW; Brass LF; Stalker TJ
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2243-2252. PubMed ID: 30674670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.
    O'Brien KA; Gartner TK; Hay N; Du X
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2232-40. PubMed ID: 22814751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis.
    Cornelissen I; Palmer D; David T; Wilsbacher L; Concengco C; Conley P; Pandey A; Coughlin SR
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18605-10. PubMed ID: 20930120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet packing density is an independent regulator of the hemostatic response to injury.
    Mirramezani M; Herbig BA; Stalker TJ; Nettey L; Cooper M; Weisel JW; Diamond SL; Sinno T; Brass LF; Shadden SC; Tomaiuolo M
    J Thromb Haemost; 2018 May; 16(5):973-983. PubMed ID: 29488682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired activation of murine platelets lacking G alpha(i2).
    Jantzen HM; Milstone DS; Gousset L; Conley PB; Mortensen RM
    J Clin Invest; 2001 Aug; 108(3):477-83. PubMed ID: 11489941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.